Mark Petrie is Professor of Cardiology in the Institute of Cardiovascular and Medical Sciences at the University of Glasgow, and a cardiologist at the Golden Jubilee National Hospital, Glasgow, and Glasgow Royal Infirmary, UK. Professor Petrie started his studies as an undergraduate at the University of Edinburgh, UK, before training in cardiology in Glasgow. He worked as a heart failure and interventional cardiologist for many years before transferring to the University of Glasgow in 2016.
Professor Petrie's research interests focus on diabetes and cardiovascular disease, heart failure, structural intervention in heart failure, revascularisation in heart failure, peripartum cardiomyopathy, microvascular disease in heart failure with preserved ejection fraction, post-myocardial infarction cardiac remodelling, iron in heart failure and cardio-oncology.
Professor Petrie has leadership roles in many trials including REVIVED, REDUCE-LAP, Dapa-HF, PARADISE-MI, EMPACT-MI, FINEARTS, SUBCUT-HF, REALIZE-K, STEP-HF, RELIEHF-HF and IRONMAN. He has been on the clinical events committees of over 40 trials, including EMPA-REG OUTCOMES, DELIVER, TRUE-HF, CARMELINA and CAROLINA. He was an author of the 2011 European Society of Cardiology (ESC) non-ST-segment elevation myocardial infarction guidelines, and a reviewer of the 2016 ESC heart failure guidelines. He was second author of the ESC position statement on diabetes and heart failure. Throughout his career, Professor Petrie has published around 180 original manuscripts including many in high-impact journals, such as New England Journal of Medicine, The Lancet, European Heart Journal, Journal of the American College of Cardiology and Circulation.